Schedule 13D ownership disclosure

LogicBio Therapeutics, Inc.

Security class unavailable · CUSIP: 54142F102

Event date: 2020-10-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-20-000780
Form type
SC 13D/A
Filer
LogicBio Therapeutics, Inc.
CIK
CIK 1664106
Filed
Oct 06, 2020
Reporting period
Oct 01, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub